You just read:

ZALTRAP® (ziv-aflibercept) Approved in the EU for Patients with Previously Treated Metastatic Colorectal Cancer

News provided by

Regeneron Pharmaceuticals, Inc.

Feb 05, 2013, 01:05 EST